Reply to: Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico.
作者信息
Vidal-Cevallos Paulina, Higuera-De-La-Tijera Fatima, Chávez-Tapia Norberto C, Sánchez-Girón Francisco, Reyes Eira Cerda, Rosales-Salyano Victor Hugo, Servin-Caamaño Alfredo, Vázquez-Medina Martín Uriel, Méndez-Sánchez Nahum
机构信息
Obesity and Digestive Disease Unit, Medica Sur Clinic and Foundation, Mexico.
Gastroenterology and Hepatology Department, Mexico's General Hospital "Dr. Eduardo Liceaga", Mexico.
出版信息
Ann Hepatol. 2021 Sep-Oct;24:100354. doi: 10.1016/j.aohep.2021.100354. Epub 2021 Apr 24.
Abstract
摘要
相似文献
1
Reply to: Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico.回复：与墨西哥新冠肺炎住院患者死亡率相关的乳酸脱氢酶
Ann Hepatol. 2021 Sep-Oct;24:100354. doi: 10.1016/j.aohep.2021.100354. Epub 2021 Apr 24.
2
Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico.乳酸脱氢酶与墨西哥新冠肺炎住院患者的死亡率相关。
Ann Hepatol. 2021 Sep-Oct;24:100348. doi: 10.1016/j.aohep.2021.100348. Epub 2021 Apr 14.
3
Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico: a multi-centre retrospective cohort study.乳酸脱氢酶与墨西哥 COVID-19 住院患者死亡率的关系：一项多中心回顾性队列研究。
Ann Hepatol. 2021 Sep-Oct;24:100338. doi: 10.1016/j.aohep.2021.100338. Epub 2021 Feb 26.
4
LOW-HARM score predicted mortality in patients hospitalized with COVID-19 in Mexico.LOW-HARM评分可预测墨西哥因COVID-19住院患者的死亡率。
Ann Intern Med. 2021 May;174(5):JC59. doi: 10.7326/ACPJ202105180-059. Epub 2021 May 4.
5
Risk Factors and Clinical Phenotypes Associated with Severity in Patients with COVID-19 in Northeast Mexico.墨西哥东北部 COVID-19 患者严重程度相关的风险因素和临床表型。
Vector Borne Zoonotic Dis. 2021 Sep;21(9):720-726. doi: 10.1089/vbz.2021.0016. Epub 2021 Jul 13.
6
COVID-19 in the Context of Inborn Errors of Immunity: a Case Series of 31 Patients from Mexico.COVID-19 与先天性免疫缺陷：来自墨西哥的 31 例患者的病例系列。
J Clin Immunol. 2021 Oct;41(7):1463-1478. doi: 10.1007/s10875-021-01077-5. Epub 2021 Jun 10.
7
Clinical Characteristics and Mortality of Health-Care Workers With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Mexico City.墨西哥城感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的医护人员的临床特征及死亡率
Clin Infect Dis. 2021 Jul 1;73(1):e199-e205. doi: 10.1093/cid/ciaa1465.
8
SARS-CoV-2 infection fatality rate after the first epidemic wave in Mexico.墨西哥首轮疫情过后的 SARS-CoV-2 感染病死率。
Int J Epidemiol. 2022 May 9;51(2):429-439. doi: 10.1093/ije/dyac015.
9
Oxidative Stress Biomarkers and Their Association with Mortality among Patients Infected with SARS-CoV-2 in Mexico.墨西哥感染 SARS-CoV-2 患者的氧化应激生物标志物及其与死亡率的关系。
Oxid Med Cell Longev. 2022 Jun 17;2022:1058813. doi: 10.1155/2022/1058813. eCollection 2022.
10
Linking lactate dehydrogenase to the severity of COVID-19 cannot ignore the employed methodology.将乳酸脱氢酶与新冠病毒疾病的严重程度联系起来不能忽视所采用的方法。
Am J Emerg Med. 2021 Jul;45:652-653. doi: 10.1016/j.ajem.2020.10.077. Epub 2020 Nov 2.
本文引用的文献
1
Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico: a multi-centre retrospective cohort study.乳酸脱氢酶与墨西哥 COVID-19 住院患者死亡率的关系：一项多中心回顾性队列研究。
Ann Hepatol. 2021 Sep-Oct;24:100338. doi: 10.1016/j.aohep.2021.100338. Epub 2021 Feb 26.
2
Lactate dehydrogenase is associated with 28-day mortality in patients with sepsis: a retrospective observational study.乳酸脱氢酶与脓毒症患者28天死亡率相关：一项回顾性观察研究。
J Surg Res. 2018 Aug;228:314-321. doi: 10.1016/j.jss.2018.03.035. Epub 2018 Apr 25.
3
Lactic Acidosis in Sepsis: It's Not All Anaerobic: Implications for Diagnosis and Management.脓毒症性乳酸酸中毒：并非全是无氧代谢：对诊断和治疗的影响。
Chest. 2016 Jan;149(1):252-61. doi: 10.1378/chest.15-1703. Epub 2016 Jan 6.
Zotero 插件